Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Change in Receivables (2022 - 2023)

Silo Pharma (SILO) has disclosed Change in Receivables for 2 consecutive years, with $1210.0 as the latest value for Q3 2023.

  • Quarterly Change in Receivables changed 0.0% to $1210.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $3590.0 through Dec 2023, down 25.21% year-over-year, with the annual reading at $3590.0 for FY2023, 25.21% down from the prior year.
  • Change in Receivables hit $1210.0 in Q3 2023 for Silo Pharma, up from $1197.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $1210.0 in Q3 2022 to a low of $1183.0 in Q1 2023.